The Chinese NDRC imposes fines on several foreign infant milk formula companies for price fixing (Nestlé, Abbott Laboratories)

The Second RPM Investigation by NDRC within this Year* In May 2013, the National Development and Reform Commission (“NDRC“) initiated the investigation against several infant formula companies for the alleged violation of Article 14 of the Antimonopoly Law (“AML“). This is the second investigation by NDRC against resale price maintenance (“RPM“). Early this year, NDRC fined China’s famous producers of premium liquor, Kweichow Moutai Co Ltd. (Maotai) and Wuliangye Group Co., Ltd. (Wuliangye) in the amount of RMB 247 million (about USD 39.8 million) for RPM behaviors (Maotai/Wuliangye Case). The current investigation is still ongoing and no penalty against any companies has been made. In both RPM investigations of this year, more than one company was investigated and the investigated

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • King & Wood Mallesons (Beijing)

Quotation

Susan Ning, The Chinese NDRC imposes fines on several foreign infant milk formula companies for price fixing (Nestlé, Abbott Laboratories), 7 August 2013, e-Competitions Bulletin August 2013, Art. N° 55065

Visites 216

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues